CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
Treatment Options in Advanced Lymphoma: CAR T-Cell vs. Bispecific Antibodies
This chapter examines treatment options for lymphoma patients facing disease progression after standard therapies, focusing on the comparison between CAR T-cell therapy and bispecific antibodies. A case study of a frail elderly patient underscores the complexities in making tailored treatment choices based on individual health factors and past treatments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
